Current Perspectives on Genotype Classification and Individualized Drug Targeting in Triple-Negative Breast Cancer

Tropical Journal of Pharmaceutical Research - Nigeria
doi 10.4314/tjpr.v17i2.23
Full Text
Abstract

Available in full text

Date
Authors
Publisher

African Journals Online (AJOL)

Related search

Targeting MYC for Triple-Negative Breast Cancer Treatment

Oncoscience
Cancer ResearchOncology
2018English

Targeting DNA Methylation for Treating Triple-Negative Breast Cancer

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2019English

Development of a Vaccine Targeting Triple-Negative Breast Cancer

2013English

Triple-Negative Breast Cancer

2018English

Advances in Small-Molecule Drug Discovery for Triple-Negative Breast Cancer

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2015English

Targeting Stromal Remodeling and Cancer Stem Cell Plasticity Overcomes Chemoresistance in Triple Negative Breast Cancer

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Dasatinib Sensitises Triple Negative Breast Cancer Cells to Chemotherapy by Targeting Breast Cancer Stem Cells

British Journal of Cancer
Cancer ResearchOncology
2018English

Triple Negative Breast Cancer: Breast Cancer Research in Evolution

Breast Disease
MedicineCancer ResearchOncology
2011English

Activity of BET-proteolysis Targeting Chimeric (PROTAC) Compounds in Triple Negative Breast Cancer

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy